UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

The Use of Magnetic Resonance Imaging Screening for Optic Pathway Gliomas in Children with Neurofibromatosis Type 1

The Journal of pediatrics, 2015-10, Vol.167 (4), p.851-856.e1

2015

Volltextzugriff (PDF)

A comparison of safety and efficacy of cytotoxic versus molecularly targeted drugs in pediatric phase I solid tumor oncology trials

Pediatric blood & cancer, 2017-03, Vol.64 (3), p.np-n/a

2017

Volltextzugriff (PDF)

A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory BRAF V600 Mutation-Positive Solid Tumors

Clinical cancer research, 2019-12, Vol.25 (24), p.7294-7302

2019

Volltextzugriff (PDF)

Gene Expression Analysis Identifies Potential Biomarkers of Neurofibromatosis Type 1 Including Adrenomedullin

Clinical cancer research, 2010-10, Vol.16 (20), p.5048-5057

2010

Volltextzugriff (PDF)

Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis

Neuro-oncology (Charlottesville, Va.), 2012-06, Vol.14 (6), p.790-797

2012

Volltextzugriff (PDF)

A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study

Journal of neuro-oncology, 2016-09, Vol.129 (3), p.443-451

2016

Volltextzugriff (PDF)

BK virus nephropathy in a pediatric autologous stem-cell transplant recipient

Pediatric blood & cancer, 2011-03, Vol.56 (3), p.495-497

2011

Volltextzugriff (PDF)

A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG)

Journal of neuro-oncology, 2020-09, Vol.149 (3), p.511-522

2020

Volltextzugriff (PDF)

Volumetric endpoints in diffuse intrinsic pontine glioma: comparison to cross-sectional measures and outcome correlations in the International DIPG/DMG Registry

Neuro-oncology (Charlottesville, Va.), 2022-09, Vol.24 (9), p.1598-1608

2022

Volltextzugriff (PDF)

Trametinib-associated Hyponatremia in a Child With Low-grade Glioma is Not Seen Following Treatment With Alternative MEK Inhibitor

Journal of pediatric hematology/oncology, 2021-05, Vol.43 (4), p.e550

2021

Volltextzugriff (PDF)

A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas

Journal of neuro-oncology, 2016-03, Vol.127 (1), p.53-61

2016

Volltextzugriff (PDF)

Pediatric intramedullary spinal cord tumor outcomes using the WeeFIM scale

Child's nervous system, 2018-09, Vol.34 (9), p.1753-1758

2018

Volltextzugriff (PDF)

A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: A children's oncology group phase 1 consortium study

Pediatric blood & cancer, 2013-09, Vol.60 (9), p.1452-1457

2013

Volltextzugriff (PDF)

Overcoming barriers to establishing autopsy procurement programs in pediatric patients with central nervous system tumors: a call to develop regional centers

Journal of neuro-oncology, 2021-03, Vol.152 (1), p.107-114

2021

Volltextzugriff (PDF)

Visual field outcomes in children treated for neurofibromatosis type 1–associated optic pathway gliomas: a multicenter retrospective study

Journal of AAPOS, 2020-12, Vol.24 (6), p.349.e1-349.e5

2020

Volltextzugriff (PDF)

Malignant peripheral nerve sheath tumor: Transformation in a patient with neurofibromatosis type 2

Pediatric blood & cancer, 2019-02, Vol.66 (2), p.e27520-n/a

2019

Volltextzugriff (PDF)

Gender as a disease modifier in neurofibromatosis type 1 optic pathway glioma

Annals of neurology, 2014-05, Vol.75 (5), p.799-800

2014

Volltextzugriff (PDF)

Pediatric tectal plate gliomas: a review of clinical outcomes, endocrinopathies, and neuropsychological sequelae

Journal of neuro-oncology, 2015-03, Vol.122 (1), p.169-177

2015

Volltextzugriff (PDF)

Clinical heterogeneity of desmoplastic infantile ganglioglioma: a case series and literature review

Journal of pediatric hematology/oncology, 2012-08, Vol.34 (6), p.e232-e236

2012

Volltextzugriff (PDF)

Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report

Neuro-oncology advances, 2022-01, Vol.4 (1), p.vdac055-vdac055

2022

Volltextzugriff (PDF)

Nocardia farcinica Meningitis Masquerading as Central Nervous System Metastasis in a Child With Cerebellar Pilocytic Astrocytoma

Journal of pediatric hematology/oncology, 2015-08, Vol.37 (6), p.482-485

2015

Volltextzugriff (PDF)

DIPG-67. RE-IRRADIATION PRACTICES AND OUTCOMES IN PATIENTS WITH DIPG/DMG: A REPORT FROM THE INTERNATIONAL DIPG REGISTRY

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

IMMU-17. A PHASE I STUDY OF INTRATUMORAL/PERITUMORAL HERPES SIMPLEX VIRUS-1 MUTANT HSV1716 IN PATIENTS WITH REFRACTORY OF RECURRENT HIGH-GRADE GLIOMAS: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

QOL-38. PSYCHOSOCIAL OUTCOMES OF CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND HIGH-GRADE GLIOMA (HGG) –PROSPECTIVE, LONGITUDINAL PROMIS ASSESSMENTS OF PATIENTS ENROLLED ON CONNECT PHASE I CLINICAL TRIALS

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

IMMU-09. PHASE 2 TRIAL USING INDOXIMOD-BASED CHEMO-IMMUNOTHERAPY FOR PATIENTS WITH CHILDHOOD BRAIN CANCER: INTERIM ANALYSIS OF THE GCC1949 STUDY (NCT04049669)

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Aktive Filter

KollektionNexis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Life Sciences & Biomedicine
(21)
Oncology
(17)
Humans
(15)
Male
(12)
Child
(11)
Pediatrics
(11)
Child, Preschool
(10)
Clinical Neurology
(10)
Female
(10)
Neurosciences & Neurology
(10)
Adolescent
(7)
Hematology
(7)
Medicine
(6)
Medicine & Public Health
(6)
Neurology
(6)
Prognosis
(6)
Clinical Study
(5)
Infant
(5)
Antineoplastic Agents - Therapeutic Use
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

The Use of Magnetic Resonance Imaging Screening for Optic Pathway Gliomas in Children with Neurofibromatosis Type 1

A comparison of safety and efficacy of cytotoxic versus molecularly targeted drugs in pediatric phase I solid tumor oncology trials

A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory BRAF V600 Mutation-Positive Solid Tumors

Gene Expression Analysis Identifies Potential Biomarkers of Neurofibromatosis Type 1 Including Adrenomedullin

Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis

A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study

BK virus nephropathy in a pediatric autologous stem-cell transplant recipient

A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG)

Volumetric endpoints in diffuse intrinsic pontine glioma: comparison to cross-sectional measures and outcome correlations in the International DIPG/DMG Registry

Trametinib-associated Hyponatremia in a Child With Low-grade Glioma is Not Seen Following Treatment With Alternative MEK Inhibitor

A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas

Pediatric intramedullary spinal cord tumor outcomes using the WeeFIM scale

A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: A children's oncology group phase 1 consortium study

Overcoming barriers to establishing autopsy procurement programs in pediatric patients with central nervous system tumors: a call to develop regional centers

Visual field outcomes in children treated for neurofibromatosis type 1–associated optic pathway gliomas: a multicenter retrospective study

Malignant peripheral nerve sheath tumor: Transformation in a patient with neurofibromatosis type 2

Gender as a disease modifier in neurofibromatosis type 1 optic pathway glioma

Pediatric tectal plate gliomas: a review of clinical outcomes, endocrinopathies, and neuropsychological sequelae

Clinical heterogeneity of desmoplastic infantile ganglioglioma: a case series and literature review

Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report

Nocardia farcinica Meningitis Masquerading as Central Nervous System Metastasis in a Child With Cerebellar Pilocytic Astrocytoma

DIPG-67. RE-IRRADIATION PRACTICES AND OUTCOMES IN PATIENTS WITH DIPG/DMG: A REPORT FROM THE INTERNATIONAL DIPG REGISTRY

IMMU-17. A PHASE I STUDY OF INTRATUMORAL/PERITUMORAL HERPES SIMPLEX VIRUS-1 MUTANT HSV1716 IN PATIENTS WITH REFRACTORY OF RECURRENT HIGH-GRADE GLIOMAS: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY

QOL-38. PSYCHOSOCIAL OUTCOMES OF CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND HIGH-GRADE GLIOMA (HGG) –PROSPECTIVE, LONGITUDINAL PROMIS ASSESSMENTS OF PATIENTS ENROLLED ON CONNECT PHASE I CLINICAL TRIALS

IMMU-09. PHASE 2 TRIAL USING INDOXIMOD-BASED CHEMO-IMMUNOTHERAPY FOR PATIENTS WITH CHILDHOOD BRAIN CANCER: INTERIM ANALYSIS OF THE GCC1949 STUDY (NCT04049669)

Aktive Filter

Suchergebnisse filtern